Literature DB >> 16769115

Reelin down-regulation in mice and psychosis endophenotypes.

Patricia Tueting1, Mohemed-Salim Doueiri, Alessandro Guidotti, John M Davis, Erminio Costa.   

Abstract

Reelin, a large glycoprotein secreted by telencephalic GABAergic neurons, plays an important role in neuronal guidance embryonically and in synaptic plasticity postnatally. The reeler heterozygous mouse (+/rl) appears superficially normal but has been of interest as an animal model for psychosis since the discovery that reelin is 50% down-regulated in postmortem psychotic brain. Brain abnormalities in +/rl are similar to psychotic brain and include a reduction in glutamic acid de carboxylase 67 (GAD67), dendritic arbors and spine density in cortex and hippocampus, and abnormalities in synaptic function including long-term potentiation (LTP). In spite of these abnormalities, behavioral abnormalities in +/rl are subtle and controversial. Recent findings indicate that the reelin (RELN) and GAD67 promoters are hypermethylated in GABAergic neurons of psychotic postmortem brain and that DNA methyltransferase 1 (DNMT1) is up-regulated. Hypermethlyation of RELN and GAD67 promoters can be induced by treating mice with methionine, and these mice display brain and behavioral abnormalities similar to +/rl. Thus, an animal model that combines genetic heterozygocity with epigenesis holds promise for understanding the role of Reelin down-regulation in psychosis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16769115     DOI: 10.1016/j.neubiorev.2006.04.001

Source DB:  PubMed          Journal:  Neurosci Biobehav Rev        ISSN: 0149-7634            Impact factor:   8.989


  34 in total

Review 1.  Lipoprotein receptors--an evolutionarily ancient multifunctional receptor family.

Authors:  Marco Dieckmann; Martin Frederik Dietrich; Joachim Herz
Journal:  Biol Chem       Date:  2010-11       Impact factor: 3.915

2.  Mouse ES cells overexpressing DNMT1 produce abnormal neurons with upregulated NMDA/NR1 subunit.

Authors:  Leonardo D'Aiuto; Roberto Di Maio; K Naga Mohan; Crescenzio Minervini; Federica Saporiti; Isabella Soreca; J Timothy Greenamyre; J Richard Chaillet
Journal:  Differentiation       Date:  2011-04-13       Impact factor: 3.880

3.  Expanding functions of lipoprotein receptors.

Authors:  Joachim Herz; Ying Chen; Irene Masiulis; Li Zhou
Journal:  J Lipid Res       Date:  2008-11-17       Impact factor: 5.922

4.  Mutant mouse models: genotype-phenotype relationships to negative symptoms in schizophrenia.

Authors:  Colm M P O'Tuathaigh; Brian P Kirby; Paula M Moran; John L Waddington
Journal:  Schizophr Bull       Date:  2009-11-24       Impact factor: 9.306

5.  L-methionine decreases dendritic spine density in mouse frontal cortex.

Authors:  Patricia Tueting; John M Davis; Marin Veldic; Fabio Pibiri; Bashkim Kadriu; Alessandro Guidotti; Erminio Costa
Journal:  Neuroreport       Date:  2010-06-02       Impact factor: 1.837

6.  Nicotine restores Wt-like levels of reelin and GAD67 gene expression in brain of heterozygous reeler mice.

Authors:  Emilia Romano; Andrea Fuso; Giovanni Laviola
Journal:  Neurotox Res       Date:  2013-02-06       Impact factor: 3.911

Review 7.  Scent marking behavior as an odorant communication in mice.

Authors:  Hiroyuki Arakawa; D Caroline Blanchard; Keiko Arakawa; Christopher Dunlap; Robert J Blanchard
Journal:  Neurosci Biobehav Rev       Date:  2008-05-15       Impact factor: 8.989

Review 8.  Modeling the positive symptoms of schizophrenia in genetically modified mice: pharmacology and methodology aspects.

Authors:  Maarten van den Buuse
Journal:  Schizophr Bull       Date:  2009-11-09       Impact factor: 9.306

9.  Serotonin transporter clustering in blood lymphocytes of reeler mice.

Authors:  Tania Rivera-Baltanas; Raquel Romay-Tallon; Iria G Dopeso-Reyes; Héctor J Caruncho
Journal:  Cardiovasc Psychiatry Neurol       Date:  2010-04-21

10.  A new test paradigm for social recognition evidenced by urinary scent marking behavior in C57BL/6J mice.

Authors:  Hiroyuki Arakawa; Keiko Arakawa; D Caroline Blanchard; Robert J Blanchard
Journal:  Behav Brain Res       Date:  2008-02-15       Impact factor: 3.332

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.